Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Taisho Kampo Ichoyaku is an over-the-counter (OTC) gastrointestinal medicine developed and marketed by Taisho Pharmaceutical Co., Ltd. It is a traditional Japanese Kampo (herbal) formulation that combines two specific herbal prescriptions: Anchusan (also known as Annaka-san) and Shakuyakukanzoto. The medicine contains a blend of crude drugs including cinnamon, Corydalis, oyster shell (Borei), fennel, licorice, and peony root. It is indicated for the treatment of various gastrointestinal symptoms such as stomach heaviness, discomfort, gastritis, stomach pain, belching, loss of appetite, abdominal bloating, heartburn, acid indigestion, and nausea. Taisho Kampo Ichoyaku works by improving the function of a weakened stomach and relieving pain through its antispasmodic properties, making it particularly effective for individuals with weak digestive systems or those suffering from digestive issues due to irregular lifestyle habits. It is classified as a Class 2 OTC drug in Japan and is available in tablet and granule forms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Taisho Kampo Ichoyaku.